Biosynex Stock
Stocks
ALBIO
FR0011005933
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Real-time
Euronext Paris
20:25:28 28/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.8400 EUR | +0.72% |
|
+7.14% | +40.94% |
| 10-26 | Biosynex US Unit Bags $6 Million Award for DPP Biothreat Panel Assay Development | MT |
| 10-23 | A Biosynex subsidiary secures $5.7m in financing |  |
| Market Cap | 15.37M 17.13M 14.19M 12.87M 24.06M 1.63B 24.35M 170M 67.58M 853M 64.29M 62.92M 2.7B | P/E 2024 |
-0.43x | P/E 2025 | -0.19x |
|---|---|---|---|---|---|
| Enterprise Value | 68.56M 76.39M 63.31M 57.41M 107M 7.26B 109M 759M 301M 3.8B 287M 281M 12.06B | EV / Sales 2024 |
0.71x | EV / Sales 2025 | 0.68x |
| Free-Float |
40.35% | Yield 2024 * |
-
| Yield 2025 | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALBIO | Real-time | |
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| 0DL | Delayed | |
|
Börse Stuttgart
| 0DL | Delayed | |
|
Boerse Muenchen
| 0DL | Real-time | |
|
CBOE
| Real-time |
| 1 day | +0.72% | ||
| 1 week | +7.14% | ||
| Current month | -3.89% | ||
| 1 month | -6.04% | ||
| 3 months | -8.70% | ||
| 6 months | +7.14% | ||
| Current year | +40.94% |
| 1 week | 0.79 |  | 0.91 |
| 1 month | 0.78 | | 1.05 |
| Current year | 0.56 | | 1.57 |
| 1 year | 0.46 | | 1.57 |
| 3 years | 0.46 | | 8.97 |
| 5 years | 0.46 | | 28.78 |
| 10 years | 0.46 | | 30.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Larry Abensur
CEO | Chief Executive Officer | 71 | 24/06/2015 |
Thierry Paper
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/01/2015 |
Oren Bitton
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Paper
BRD | Director/Board Member | 63 | 24/06/2015 |
Thomas Lamy
BRD | Director/Board Member | - | 24/06/2015 |
Larry Abensur
CHM | Chairman | 71 | 24/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/02/23 | Buy | Director | 2,500 | 0.0244% | ||
| 15/02/23 | Buy | Director | 2,500 | 0.0244% | ||
| 28/02/22 | Buy | Chief Executive Officer | 2,000 | 0.0180% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.72% | +7.14% | +30.03% | -90.01% | 17.13M | |
| +0.01% | +2.72% | -18.46% | +11.01% | 178B | |
| +0.48% | +1.68% | -19.50% | +15.24% | 116B | |
| +0.92% | +1.98% | +1.76% | +35.59% | 115B | |
| -2.17% | +2.27% | -44.02% | +5.63% | 93.1B | |
| +0.14% | -4.22% | -2.85% | +75.86% | 62.09B | |
| +0.17% | +1.64% | +8.50% | +82.24% | 55.87B | |
| -0.44% | +0.31% | +5.83% | -22.36% | 53.12B | |
| +0.45% | +2.28% | -10.76% | +42.81% | 44.22B | |
| +0.21% | +3.22% | -2.93% | -8.61% | 33.59B | |
| Average | +0.05% | +2.22% | -5.24% | +14.74% | 75.1B | |
| Weighted average by Cap. | -0.02% | +2.37% | -12.53% | +24.05% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 101M 113M 93.41M 84.71M 158M 10.71B 160M 1.12B 445M 5.61B 423M 414M 17.8B | 95.19M 106M 87.9M 79.71M 149M 10.07B 151M 1.05B 419M 5.28B 398M 390M 16.75B |
| Net income | -43.33M -48.28M -40.01M -36.28M -67.81M -4.59B -68.65M -480M -191M -2.4B -181M -177M -7.62B | -58.22M -64.87M -53.76M -48.75M -91.12M -6.16B -92.24M -645M -256M -3.23B -244M -238M -10.24B |
| Net Debt | 52.94M 58.98M 48.88M 44.32M 82.84M 5.6B 83.86M 586M 233M 2.94B 221M 217M 9.31B | 53.19M 59.26M 49.11M 44.54M 83.24M 5.63B 84.26M 589M 234M 2.95B 222M 218M 9.36B |
Employees
397
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | €0.8400 | +0.72% | 24,174 |
| 27/10/26 | €0.8340 | -1.65% | 14,999 |
| 26/10/26 | €0.8480 | +7.34% | 26,675 |
| 23/10/26 | €0.7900 | -3.66% | 23,732 |
| 22/10/26 | €0.8200 | +4.59% | 22,830 |
- Stock Market
- Stocks
- ALBIO Stock
Select your edition
All financial news and data tailored to specific country editions
